Immix Biopharma, Inc. (IMMX) Insider Ownership

According to recent filings covering the 90 days ending January 10, 2026, the three most significant insider holders at Immix Biopharma are Ceo And Chairman Ilya M Rachman (1.14Mn shares), Director Carey Ng (1.05Mn shares), Director Jason Hsu (943.00K shares).

• Immix Biopharma, Inc. (IMMX) exhibits a conventional ownership structure with institutions commanding 8.67% of outstanding shares, insider ownership remaining at 17.44%, and public/other investors holding 73.89%.
• Current insider holdings at Immix Biopharma account for 17.44% of total shares outstanding as of January 10, 2026, totaling roughly 5.51Mn shares from the company's 31.61Mn share base.
• Throughout the 90-day span concluding January 10, 2026, Immix Biopharma's insider stake increased 0.09%, as collective insider positions growing from 5.51Mn shares to 5.51Mn shares.
• As of January 10, 2026, Cfo Gabriel S Morris emerged as Immix Biopharma's top insider buyer over the preceding 90 days, securing 156.77K shares.
• Immix Biopharma had no significant insider sales in the last 90 days.